Li-Fei Zhu
Overview
Explore the profile of Li-Fei Zhu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang K, Zhu L, Wu T, Zhang S, Yu Z
Chin J Integr Med
. 2024 Sep;
PMID: 39331210
Objective: To explore the key target molecules and potential mechanisms of oridonin against non-small cell lung cancer (NSCLC). Methods: The target molecules of oridonin were retrieved from SEA, STITCH, SuperPred...
2.
Peng P, Wang X, Shen D, Sun J, Jia Y, Xu R, et al.
Bio Protoc
. 2023 Dec;
9(24).
PMID: 38156295
[This corrects the article .].
3.
Yang S, Wang X, Zhang H, Zhu L, Qu S, Zhang M, et al.
Chem Biodivers
. 2023 Dec;
21(2):e202301781.
PMID: 38146649
Polysaccharide from Asarum sieboldii Miq (ASP) was extracted and five phosphorylation polysaccharides with different degree of substitution were obtained, namely ASPP1, ASPP2, ASPP3, ASPP4, and ASPP5 (ASPPs). The physical and...
4.
Peng P, Wang X, Shen D, Sun J, Jia Y, Xu R, et al.
Bio Protoc
. 2021 Mar;
9(2):e3141.
PMID: 33654886
In recent years, great progress has been made in the research of genome editing systems, one of which is the CRISPR-Cas9 system, a powerful technology that is applied to edit...
5.
Ye T, Mei Y, Bao D, Zhu Y, Xu X, Zhu L
Dig Liver Dis
. 2020 Dec;
53(9):1112-1117.
PMID: 33376073
Background: Anti-tumour necrosis factor (TNF)-α drugs are used by increasing numbers of reproductive-age women. Although the neonatal outcomes have been described, there are concerns regarding the risk of infection in...
6.
Cao F, Zhu L, Kuang Q, Li X, Zhou B, Yang X, et al.
Bioorg Med Chem Lett
. 2016 Nov;
27(1):55-60.
PMID: 27887841
As our continuing research, a series of 2-aryl-8-OR-3,4-dihydroisoquinolin-2-ium bromides were evaluated for cytotoxic activity on cancer cells and apoptosis induction in the present study. SAR was derived also. Among them,...
7.
Zhu L, Hou Z, Zhou K, Tong Z, Kuang Q, Geng H, et al.
Bioorg Med Chem Lett
. 2016 Apr;
26(10):2413-2417.
PMID: 27072907
As our continuing research on antifungal dihydroisoquinolin-2-ium salts, forty 2-aryl-8-OR-3,4-dihydroisoquinolin-2-ium bromides were synthesized and characterized by spectroscopic analysis. By using the mycelium growth rate method, the compounds were evaluated for...
8.
Hou Z, Zhu L, Yu X, Sun M, Miao F, Zhou L
J Agric Food Chem
. 2016 Mar;
64(14):2847-54.
PMID: 27004437
Twenty-two 2-aryl-9-methyl-3,4-dihydro-β-carbolin-2-ium bromides along with four 9-demethylated derivatives were synthesized and characterized by spectroscopic analysis. By using the mycelium growth rate method, the compounds were evaluated for antifungal activities in...
9.
Hou Z, Yang R, Zhang C, Zhu L, Miao F, Yang X, et al.
Molecules
. 2013 Sep;
18(9):10413-24.
PMID: 23994968
The title compounds are a class of structurally simple analogues of quaternary benzo[c]phenanthridine alkaloids (QBAs). In order to develop novel QBA-like antifungal drugs, in this study, 24 of the title...
10.
Zhang Y, Zhu L, Weng X
Zhong Xi Yi Jie He Xue Bao
. 2006 May;
4(3):315-7.
PMID: 16696924
No abstract available.